Ultrahuman Raises $70 Million to Build the Next Generation of Human-Computer Interface for Health

Ultrahuman, the health intelligence company building a new interface between humans and technology, today announced a $70 million financing round with participation from Qualcomm Ventures, Labcorp, Alpha Wave, Blume, Nexus, Alteria and other investors.

The financing marks the next chapter in Ultrahuman’s evolution from a wearable health company into a human-computer interface company built around the body.

Ultrahuman believes the most important computing platform of the next decade will not sit on a desk, in a pocket or on a face. It will understand the human body continuously – sleep, cardiovascular health, metabolism, hormonal rhythms, blood biomarkers, recovery and the environment around it – and turn those signals into intelligence that meaningfully improves a person’s life.

At the centre of that platform is the Ultrahuman Ring, supported by Blood Vision, continuous glucose monitoring, environmental sensing and an expanding software, AI and research layer. Together these systems are designed to build a longitudinal understanding of human physiology rather than treat health as a collection of isolated measurements.

“For the longest time, computers have understood almost everything about the world except the person using them,” said Mohit Kumar, Founder and CEO of Ultrahuman. “We want to change that. We are building an interface that can understand the body continuously and translate its signals into intelligence that is useful in everyday life. Not another dashboard and not simply more data. Something that can help a person sleep better, understand cardiovascular health, navigate fertility and improve metabolic health.”

“Building this requires us to go unusually deep across sensing, materials, electrical engineering, algorithms, physiology and clinical science. That combination is what excites us. This capital lets us push much harder on it, and bring what we build to millions of people around the world.”

From wearable to human-computer interface

Ultrahuman’s approach starts with a simple observation. The human body produces an extraordinary amount of information every second, and computing systems have historically understood very little of it.

• Ultrahuman Ring captures physiological signals continuously from the finger.
• Blood Vision brings biochemical information across cardiovascular, metabolic, hormonal, inflammatory and longevity markers.
• M1/M2 Live continuous glucose monitoring adds metabolic response.
• Ultrahuman Home adds the environment in which the body sleeps and recovers.
• Jade, Ultrahuman’s real-time biointelligence system, brings those signals together to make health information conversational, contextual and actionable.

The ambition is to move computing from systems that wait for human input to systems that understand the physiological state of the person using them.

“The future of AI is personal, ambient, and always on,’” said Quinn Li, Senior Vice President, Qualcomm Technologies, Inc., and global head of Qualcomm Ventures.  “Ultrahuman is pioneering a new generation of personal AI devices that make personalized insights effortless.  We look forward to supporting their journey as they expand the possibilities of personal AI devices.”

Science as a product advantage

Ultrahuman has approached the smart ring category as a continuously evolving scientific and computational platform rather than a device defined by a fixed set of metrics.

• AFib Detection, a world first on a smart ring, extended the role of passive wearables into cardiovascular awareness.
• Cycle & Ovulation Pro, built on OvuSense technology acquired with viO HealthTech, delivers ovulation confirmation with 90%+ accuracy, moving reproductive health insight beyond calendar-based estimation.
• Cardiovascular fitness age, examined across 442 adults in peer-reviewed work published in Frontiers in Digital Health in July 2026, extends the company’s work from consumer metrics into validated models of cardiovascular health.
• Sleep and metabolism at scale, in research developed with collaborators including Stanford University analysing 227,860 nights of concurrent data from adults across 100 countries.
• Pulsomics, launched in 2026, an opt-in research platform embedded directly into the Ultrahuman experience.

Pulsomics lets Ring users take part in large-scale studies using real-world longitudinal data rather than small controlled laboratory cohorts. Its first programmes examine individual sleep need, VO₂ Max and glucose metabolism, with further studies planned across cardiovascular load and longitudinal sleep.

For Ultrahuman it creates a direct bridge between the physiological signals consumer wearables already generate and the science needed to make the algorithms interpreting those signals more accurate and more representative. Health models trained across different body types, populations, lifestyles and geographies can become substantially more personalised than models developed from traditional research cohorts alone.

“Ultrahuman is taking an innovative approach to helping people better understand their health through continuous data and insights,” said Megann Vaughn Watters, Vice President and Head of Labcorp Venture Fund & Strategic Alliances. “By combining longitudinal wearable data with deeper biological signals, Ultrahuman is creating new opportunities in personalized health. We’re excited to support the company as it scales its platform and advances the future of health insights.”

A platform designed to keep learning

Ultrahuman’s engineering philosophy is that a wearable should become substantially more capable after it has been bought.

• PowerPlugs allow specialised health capabilities to be built on top of the platform, across cardiovascular health, reproductive health, circadian alignment, respiratory health, shift work, pregnancy, metabolic health and migraine insights.
• UltraSignal opens wearable sensor streams to new algorithms and health experiences.
• Ring PRO moves more computation onto the wearable itself through a new sensing architecture, on-chip machine learning and expanded on-device storage.

Together these turn the ring from a fixed-purpose tracker into something closer to an extensible biological computer, whose capabilities keep expanding as better sensors, algorithms, research and AI arrive.

Building health intelligence at global scale

“Proud to have two American giants bring a whole new level of deep insights and technology stack to the world’s most advanced health tracking ecosystem”, said Hussain Ahamed (global strategy advisor, who served as key interface with Qualcomm and Labcorp).

The new capital accelerates research and development across sensing, AI, miniaturised electronics and health algorithms; deepens investment in clinical science and large-scale research; extends the reach of Blood Vision and the metabolic health platform; and brings the ecosystem to more people globally.

Our process is: build the sensing layer close enough to the body to capture high-quality continuous signal. Connect that signal to deeper biological information. Train increasingly sophisticated models using real-world science. Make the resulting intelligence useful in everyday life.

What began with a smart ring is becoming a much broader mission: a computing platform that understands the human.